Precision Biosciences DTIL Cash Flow Statement (2018-2026)

NASDAQ DTIL
$6.75 +0.04 (+0.59%)
As of: Oct 22, 2026 · 10:22 AM EDT
Reported Financials

Precision Biosciences Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Precision Biosciences reported cash from operations of -$13.44M and free cash flow of -$13.44M for the quarter ended Jun 2026, up 33.7% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-11.28M-22.29M-28.17M-31.04M-23.95M-28.49M-25.06M-11.89M-8.08M-16.29M8.59M32.75M-16.43M-17.75M-20.57M-23.52M-21.77M20.13M-18.44M-32.65M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.02M0.02M0.02M0.11M0.09M0.09M0.21M0.05M0.05M0.05M0.23M0.03M-0.03M0.02M0.13M0.01M0.02M0.02M0.12M0.00M
Depreciation & Amortization (CF)Dep. & Amort.
2.26M2.18M1.97M1.93M1.94M1.96M1.95M1.97M1.62M1.28M1.14M1.09M0.72M0.45M0.40M0.38M0.35M0.38M0.30M0.25M
Share-based CompensationStock Comp.
4.55M4.44M4.39M5.14M5.13M4.54M4.09M3.87M3.11M2.97M2.91M2.93M3.20M3.57M2.82M2.94M2.39M2.04M1.55M1.84M
Gains from Equity InvestmentsGains Equity
-0.95M-1.45M-1.78M2.60M-1.34M-1.37M-1.35M-0.87M1.71M-0.95M-0.88M-0.97M1.34M-0.67M-0.59M-5.37M
Gains from Sales and DivestituresGains Divest
0.00M-0.01M-0.05M-0.05M-0.01M0.07M8.38M-0.07M-0.19M-0.18M-0.01M-0.03M0.00M0.89M0.00M0.00M
Gains from Investment SecuritiesGains Investment
-0.77M
Other non-cash itemsOther Non-Cash
-17.59M-2.25M0.20M0.21M0.22M0.73M1.00M0.33M-0.02M-1.53M-9.87M-8.34M-4.15M-7.04M0.79M-0.75M1.28M-11.78M10.40M13.89M
Change in Working Capital
Change in ReceivablesChange Receivables
-49.79M0.01M-0.03M-0.04M2.84M-2.59M-0.51M-0.18M-0.02M0.04M-0.23M0.00M0.00M0.00M4.00M-4.00M
Change in Account PayablesChange Payables
0.05M0.63M-0.37M-0.20M0.39M0.34M-0.56M0.12M-0.05M2.00M-2.10M0.12M-0.19M0.07M-0.11M0.20M0.22M-1.05M0.65M-0.12M
Change in Accured ExpensesChange Accured Exp.
-0.07M2.40M-5.15M2.44M0.47M0.42M-4.52M1.03M0.39M2.38M-5.84M1.82M2.04M-0.16M-5.12M0.68M0.53M2.15M-1.80M-0.55M
Change in Other Operating AssetsOther Assets Change
-2.62M-3.16M-0.55M-4.26M4.35M-0.02M1.44M-1.03M-0.90M-2.31M4.69M-3.55M-8.25M-0.45M-3.58M3.16M-1.49M-3.24M0.35M0.41M
Change in Other Operating LiabilitiesOther Liabilities Change
-3.71M12.51M-3.26M47.12M-6.65M-11.67M-8.52M-18.97M-11.08M-6.33M-8.21M-50.14M-0.84M-0.81M-0.34M-0.34M-0.35M-26.56M-0.36M-0.37M
Other Working Capital ChangesOther WC Changes
-1.09M15.67M-2.72M51.38M-11.00M-11.66M-9.96M-17.94M-10.18M-4.02M-12.90M-46.60M7.42M-0.36M3.24M-3.50M1.14M-23.32M-0.71M-0.78M
Cash from OperationsCash from Ops.
-23.91M-23.68M-28.87M-24.22M29.19M-21.84M-31.46M-21.13M-23.09M-8.42M-18.98M-14.87M-5.91M-18.68M-19.05M-20.27M-15.27M-11.25M-11.94M-13.44M
Investing Activities
Capital ExpendituresCapex
0.73M1.51M0.82M0.78M1.09M0.63M0.52M1.08M0.39M-0.03M0.09M0.03M0.04M0.10M0.06M0.00M0.02M0.02M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.04M0.06M0.01M0.02M0.04M0.00M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.73M-1.51M-0.82M-0.78M-1.09M-0.63M-0.52M-1.08M-0.39M0.06M-0.03M-0.03M-0.04M-0.10M-0.06M0.00M0.02M0.03M-0.01M0.00M
Change in IntangiblesChange Intangibless
0.20M0.05M0.05M0.02M0.03M0.25M0.02M0.35M0.10M
Change in Acquisitions & DivestmentsChange Acquisitions
0.61M1.38M0.46M-5.00M0.08M
Cash from Investing ActivitiesCash from Investing
-1.48M-1.51M-0.82M-0.78M-1.09M-0.63M-0.72M-1.06M7.56M0.04M-0.03M-0.03M-0.06M-0.10M-0.31M-0.01M0.02M-0.33M-0.11M0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-0.01M2.51M-0.16M-0.01M-0.02M
Non-Current Debt
-0.01M2.51M-0.16M-0.01M-0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.01M2.51M-0.16M-0.01M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
11.92M8.37M2.25M47.95M-0.02M0.01M0.30M0.10M0.00M0.11M0.14M0.14M0.08M0.08M
Net Shares Issued and RepurchasedNet Shares Issued
11.92M8.37M2.25M47.95M-0.02M0.01M0.30M0.10M0.00M0.11M0.14M0.14M0.08M0.08M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
11.92M8.37M2.25M47.95M-0.02M0.01M0.30M0.10M0.00M0.11M0.14M0.14M0.08M0.08M
Other financing activitiesOther financing
0.19M0.91M1.03M0.66M
Cash from Financing ActivitiesCash from Financing
11.92M8.38M2.25M92.92M-0.18M0.74M1.85M-0.03M2.83M40.10M0.70M3.73M5.92M10.69M5.30M1.66M77.52M0.75M
Additional items
Change in Cash
-13.47M-16.81M-27.44M67.91M27.92M-22.48M-31.44M-20.34M-15.56M-5.55M21.09M-14.20M-2.24M-12.86M-8.68M-14.98M-13.59M65.94M-11.31M-13.44M
Ending Cash Balance
160.47M143.66M116.22M184.14M212.05M189.58M158.13M137.79M122.23M116.68M137.77M123.57M121.33M108.47M99.79M84.81M71.21M137.15M125.85M112.41M
Free Cash FlowFCF
-24.64M-25.19M-29.69M-25.00M28.10M-22.48M-31.99M-22.21M-23.48M-8.40M-19.07M-14.90M-5.95M-18.78M-19.12M-20.27M-15.27M-11.27M-11.96M-13.44M
Net Cash FlowNCF
-13.47M-16.81M-27.44M67.91M27.92M-22.48M-31.44M-20.34M-15.56M-5.55M21.09M-14.20M-2.24M-12.86M-8.68M-14.98M-13.59M65.94M-11.31M-13.44M
Interest Paid
0.03M0.03M0.03M0.07M0.32M0.40M0.46M0.50M0.52M0.53M0.53M0.53M0.31M0.37M0.34M0.35M0.35M0.33M0.30M0.30M

Precision Biosciences Cash Flow Statement API

Pull Precision Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DTIL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY